Dawa Life Sciences

What Dawa Life Sciences does

Dawa Life Sciences is a privately held Kenyan pharmaceutical and animal health company headquartered in Nairobi with primary manufacturing operations in Thika, Kenya. Founded in 1994 by Dr. Raju Mohindra and Dr. Ajay Patel, the company operates two integrated divisions: a human pharmaceuticals division (formerly Dawa Limited, acquired in 2004) manufacturing 190+ generic pharmaceutical products across therapeutic areas including infectious diseases, cardiology, neurology, gastroenterology, and endocrinology; and Medisel, an animal health division producing antimicrobials, anthelmintics, nutritional supplements, and vaccines for livestock and companion animals. The company's core technology infrastructure comprises GMP-accredited manufacturing facilities, including a dedicated Beta Lactam facility (2013) and Animal Health manufacturing facility (2016), supported by SAP ERP systems for finance and manufacturing operations.

The company generates revenue through B2B distribution of pharmaceutical and animal health products across 25 markets in Sub-Saharan Africa, delivering over 100 million treatments annually through an integrated manufacturing-to-distribution supply chain. Its go-to-market model combines dedicated sales teams for Branded, Essential Health, and International Business divisions with a distributor partnership program. Revenue was US$60 million in 2020 across 1,000+ product lines, with international business constituting approximately 25-30% of total turnover. The company holds ISO 9001:2015 certification and GMP accreditation, and has been recognized with Superbrands Status in East Africa.

Dawa Life Sciences is founder-owned with no disclosed institutional investment, operating through wholly owned subsidiaries Dawa Limited (pharmaceutical manufacturing) and Medisel Kenya Limited (animal health). The company recently unified its corporate identity as Dawa Life Sciences in 2021 and has pursued an active product launch cadence through 2026, including new cardiovascular, renal, and gastroenterology products. Strategic partnerships in 2025 with Ilara Health (healthcare clinic operations) and participation in the Axmed Access Summit indicate ambitions to expand beyond traditional pharmaceutical manufacturing into broader healthcare ecosystem participation.

Name

Dawa Life Sciences

Legal name

Dawa Life Sciences

Website

https://dawalifesciences.com

Company type

Private

Founded year

1994

Operating status

Operating

Headcount range

501–1,000 employees

Short description

Dawa Life Sciences is a Kenyan pharmaceutical and animal health manufacturer producing 190+ generic medicines and veterinary products across 25 Sub-Saharan African markets. It operates GMP-accredited facilities delivering over 100 million treatments annually to healthcare providers, pharmacies, government tenders, and livestock farmers.

Ownership category

akta.pro rank

Product category

Generic Pharmaceuticals

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (32541)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

Generic Hospital & Institutional Products (HLAIABAL)

akta.pro secondary industry

Primary Care & General Medicine Pharmaceuticals (HLAIAAAA)

Keywords

• Generic pharmaceuticals
• Animal health products
• Pharmaceutical manufacturing
• GMP manufacturing
• Veterinary medicines

Headquarters

HQ city

Nairobi

HQ country

Kenya

HQ region

Africa

Offices5 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Operations, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Pharmaceutical Manufacturing and Distribution: Manufactures and distributes generic pharmaceuticals across Africa. Provides over 100 million treatments annually through integrated manufacturing and distribution network.

Pricing tiers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

Core offering

Dawa Life Sciences manufactures and distributes affordable, high-quality generic pharmaceuticals for human health and animal health products through GMP-accredited facilities in Kenya. The company produces over 190 products spanning cardiovascular, anti-infective, neurology, gastroenterology and endocrinology therapeutic areas, delivering more than 100 million treatments annually across 25 Sub-Saharan African markets through an integrated manufacturing and distribution network.

Product overview

Dawa Life Sciences is a pharmaceutical and animal health company operating two main divisions: Pharmaceuticals (human health) and Medisel - Animal Health. The company manufactures over 190 pharmaceutical products and numerous animal health products across 25 markets in Sub-Saharan Africa. Human health products span therapeutic areas including cardiovascular medications (Amlodawa, Nephix, Varstal, Lowchol, Clotel, Arnisto, Bedoic), anti-infectives/antibiotics (Amclamed, Amoximed, Ampecin, Kenazole), analgesics/NSAIDs (Acepar), emergency medicine (Adrenaline, Dawadur), and gastroenterology (Rifaxio). Animal health products include antimicrobials, antiprotozoals, probiotics, disinfectants, anthelmintics, nutritional supplements, and mineral supplements for livestock and companion animals. The company operates GMP-accredited manufacturing facilities including dedicated Beta Lactam and Animal Health facilities, with ISO 9001:2015 certification.

Differentiator

Problem solved

Functional benefit

Brands

• Medisel: Animal health division of Dawa Life Sciences, providing affordable, high-quality animal health and nutrition products in East and Central Africa.

Products and services

• Pharmaceuticals (Human Health Division) Core pharmaceutical division manufacturing and distributing generic medications across therapeutic areas including infectious diseases, cardiology, neurology, gastroenterology and endocrinology. Provides over 100 million treatments annually across 25 markets in Africa.
• Medisel - Animal Health Division Animal health and nutrition division producing liquids, sachets, boluses, premixes, and external preparations for livestock and companion animals including antimicrobials, anthelmintics, nutritional supplements, probiotics, and vaccines.
• Nephix 10mg Tablets Cardiovascular/renal management medication containing Finerenone 10mg for chronic kidney disease (CKD) associated with type 2 diabetes. Available as 3 x 10 tablets.
• Nephix 20mg Tablets Cardiovascular/renal management medication containing Finerenone 20mg for chronic kidney disease (CKD) associated with type 2 diabetes. Available as 3 x 10 tablets.
• Rifaxio 550mg Tablets Gastroenterology/infectious disease medication containing Rifaximin 550mg. Indicated for IBS-D management and prevention of recurrent hepatic encephalopathy. Available as 1 x 10 Tablets.
• Amclamed Tablets Anti-infective (antibiotic) combining Amoxicillin 500mg and Clavulanic Acid 125mg for treatment of bacterial infections. Available in 500mg + 125mg strength, 10's pack size.
• Varstal 10-Plus Tablets Cardiovascular combination medication with Amlodipine 10mg + Valsartan 160mg + Hydrochlorothiazide 12.5mg for hypertension management.
• Varstal 5-Plus Tablets Cardiovascular combination medication with Amlodipine 5mg + Valsartan 160mg + Hydrochlorothiazide 12.5mg for hypertension management.
• Lowchol Tablets Cardiovascular lipid-lowering agent/statin containing Atorvastatin 20mg for cholesterol management.
• Dawadur 2.4 MEGA Injection Antibiotic injection containing Benzathine Benzylpenicillin B.P. 2,400,000 I.U. for treatment of bacterial infections.
• Amlodawa 5mg Tablets Cardiovascular medication for hypertension management containing Amlodipine 5mg, 30's pack.
• Amlodawa 10mg Tablets Cardiovascular medication for hypertension management containing Amlodipine 10mg, 30's pack.
• Arnisto 50mg Tablets Chronic heart failure medication containing Sacubitril 24.3mg and Valsartan 25.7mg for HFrEF treatment.
• Arnisto 100mg Tablets Chronic heart failure medication containing Sacubitril 48.6mg and Valsartan 51.4mg for HFrEF treatment. Available in 50mg and 100mg strengths, 30's pack.
• Bedoic 180mg Tablets Cholesterol-lowering medication containing Bempedoic Acid 180mg for reducing LDL in statin-refractory patients.
• Bedoic-EZ 180/10mg Tablets Cholesterol combination tablet containing Bempedoic Acid 180mg and Ezetimibe 10mg for reducing LDL-C levels in primary hyperlipidemia.
• Acepar Caplets NSAID analgesic combining Aceclofenac 100mg + Paracetamol 500mg for pain management.
• Amoximed 250mg Capsules Anti-infective antibiotic capsule containing Amoxicillin Trihydrate 250mg for treatment of bacterial infections.
• Amoximed 500mg Capsules Anti-infective antibiotic capsule containing Amoxicillin Trihydrate 500mg for treatment of bacterial infections.
• Adrenaline Injection Emergency medicine injection containing Adrenaline (Epinephrine) 1mg/mL (1:1000) for anaphylaxis management.
• Alcof Expectorant Cough syrup containing Ammonium 110mg + Chlorpheniramine 2.0mg + Sodium Citrate 50mg for cough relief.
• Amclamed Powder for Oral Suspension Pediatric antibiotic suspension with Amoxicillin 200mg and Clavulanic Acid 28.5mg in 70ml bottle.
• Ampecin Dry Powder for Suspension Anti-infective antibiotic suspension containing Ampicillin 125mg/5ml for treatment of bacterial infections. Available in 60ml and 100ml.
• Kenazole 200mg Tablets Antifungal medication containing Ketoconazole 200mg for treatment of systemic and superficial fungal infections including dermatophytosis and candidiasis.
• Dawa-Tylodoxy 200 Animal health antimicrobial containing Doxycycline Hyclate 200mg and Tylosin tartrate 200mg for respiratory and gastrointestinal infections in poultry, swine, sheep, goats and calves.
• MicroGuard-E Animal health probiotic containing lactic acid bacteria and Bacillus species fortified with Saccharomyces boulardii for intestinal pathogen defense.
• Damina-Vet Animal health antiprotozoal containing Diminazene Diaceturate 1.05g and Antipyrine 1.31g for treatment of trypanosomiasis and piroplasmosis in cattle, sheep, horses and dogs.
• Amidiostat-Plus Animal health antimicrobial/antiprotozoal containing Amprolium Hydrochloride 200mg and Sulphaquinoxaline Sodium 150mg for coccidiosis and bacterial infections.
• Dawa Cleanse Animal health disinfectant containing Glutaraldehyde 15% w/v and Benzalkonium Chloride 10%w/v effective against bacteria, viruses and fungi with seven-day residual effect.
• Medisel Epsom Salt Animal health laxative containing Magnesium Sulphate for relief of constipation and livestock vitality restoration.
• Dawa Tylosin Animal health antimicrobial macrolide containing Tylosin tartrate 200mg for respiratory infections and other micro-organism sensitive infections.
• Dawa Pen-Strep Animal health antibiotic combination containing Procaine Penicillin Bp250mg and Dihydrostreptomycin Sulphate for mixed Gram-positive and Gram-negative infections.

Quantifiable outcome

• Over 100 million treatments provided annually across 25 markets
• +2 more outcomes

Named customers5 records

Segments3 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Seven partnerships are on record, tiered core and minor.

• Ilara HealthcoreStrategic or Co-development Partner · 1 January 2025Partnership to operate AfyaNzima Healthcare Clinic within Dawa Life Sciences premises. The clinic provides fast, efficient first response for occupational injuries and affordable healthcare access for employees and surrounding community. Supports OSHA Act 2007 compliance.
• Kenya Obstetrical and Gynaecological Society (KOGS)minorStrategic or Co-development Partner · 1 January 2025Healthcare partnership for women's health. Dawa Life Sciences participated in KOGS Conference 2025 to engage with healthcare professionals, exchange knowledge, and showcase products for women's health including Hemoflux, Spasmocare, Emadon, Dobesil H, Dub-sterone and Doloact-Plus.
• AxmedminorStrategic or Co-development Partner · 1 January 2025Innovation in Local Manufacturing partnership. Managing Director Dr. Ajay Patel participated as panelist at Axmed Access Summit 2025 to share insights on innovative strategies for local manufacturers and breaking down access barriers.
• Thika Subcounty Clinical OfficersminorStrategic or Co-development Partner · 1 January 2025Healthcare professional education partnership. Hosted Continuing Medical Education (CME) session on Management of Diabetes using First-Line Therapy focusing on treatments such as Metformin and Amlodipine with latest best practices in patient care.
• East Africa Kennel Club (EAKC)minorStrategic or Co-development Partner · 1 January 2024Animal health division (Medisel Kenya Limited) participation in 174th All Breed Championship Dog Show. Engaged with dog owners, breeders and enthusiasts showcasing pet health products including nutritional supplements and grooming essentials.
• Kenya Wildlife Service (KWS)minorStrategic or Co-development Partner · 1 January 2023Environmental sustainability partnership for tree planting initiative. Dawa Life Sciences, KWS and community at Kilimambogo planted 1,400 trees to support environmental conservation and community engagement.
• United States International University - Africa (USIU-Africa)minorStrategic or Co-development Partner · 1 January 2022Dual Vocational Training Program for Pharmaceutical Production Specialists sponsored by German Metrology Institute (PTB). Program provides training for young students to qualify as pharmaceutical production operators through 12-month course with industry collaboration.

Scale indicators7 records

Recent moves12 records

Expansion highlights6 records

Direct peers

• Cipla: Indian-headquartered global generic manufacturer with deep Africa presence and ARV/anti-infective focus. Directly competes with Dawa in African generic markets, particularly in infectious diseases and chronic therapeutic areas.
• Sun Pharmaceutical Industries: World's fourth-largest generic pharmaceutical manufacturer with significant African market penetration through branded generics. Directly comparable as an Indian generic heavyweight competing for African generics and chronic-disease share.
• Regal Pharmaceuticals: East African pharmaceutical manufacturer producing generics across antibiotics, cardiovascular, and consumer health categories. Direct regional peer to Dawa with overlapping product portfolio and East African distribution footprint.
• Aspen Pharmacare: Largest African-headquartered pharmaceutical manufacturer (South Africa), operating across generics, branded, and consumer health with pan-African and global distribution. Directly comparable to Dawa as a vertically integrated African generic pharma manufacturer targeting similar therapeutic categories.
• Universal Corporation Limited (UCL): Kenyan pharmaceutical manufacturer and distributor producing generics and consumer health products for East Africa. Direct domestic competitor to Dawa Life Sciences in the Kenyan pharma market with overlapping therapeutic categories.
• Emzor Pharmaceutical Industries: Nigerian pharmaceutical manufacturer producing generics, OTC products, and consumer health items across West Africa. Comparable to Dawa as an African regional pharma manufacturer serving similar generics categories with local manufacturing.
• Adcock Ingram: South African pharmaceutical manufacturer with prescription, consumer health, and hospital portfolios. Comparable as a Sub-Saharan Africa-based pharma manufacturer operating across generics and branded products with established distribution networks.

Emerging players

• Strides Pharma Science: Indian generic pharmaceutical company with Africa-focused branded generics strategy. Comparable to Dawa in targeting African generics with therapeutic focus areas including anti-infectives and chronic disease.

Broad incumbents

• Sanofi: Global pharmaceutical multinational with established African presence across branded, generic, and consumer health. Comparable as a broad incumbent competing with Dawa across cardiovascular, diabetes, and infectious disease categories in African markets.
• GSK (GlaxoSmithKline): Global pharmaceutical and consumer healthcare company with substantial African operations including anti-infectives, vaccines, and chronic disease medications. Broad incumbent that competes with Dawa across multiple therapeutic areas in Sub-Saharan markets.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xx.com/dawalifescience
• LinkedInlinkedin.com/company/dawa-life-sciences

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Dawa Life Sciences